metricas
covid
Annals of Hepatology Last published articles
Journal Information

Last published articles

Letters to the editor
Toward standardization and translation of stem cell therapy in liver failure
Parth Aphale, Himanshu Shekhar, Shashank Dokania
Ann Hepatol. 2026;31:102164
Full text access
Original article
Early-life exposure to tobacco smoke and chronic liver disease incidence in adulthood
Xiaoqin Xu, Jiang Li, Yanqi Fu, Jie Li, Wenqi Shen, Xiao Tan, Jinyi Wu, Ningjian Wang, ... Bin Wang
Ann Hepatol. 2026;31:102168
Full text access
Letters to the editor
Beyond the epidemiological link: Targeting the gut-liver-kidney axis in hepatorenal disease
Songhe Chen, Ye Chen, Kai Chen
Ann Hepatol. 2026;31:102163
Full text access
Original article
Assessment of metabolic dysfunction-associated steatotic liver disease, alcohol-associated liver disease, and metabolic dysfunction and alcohol-associated steatotic liver disease in open Mexican population
Jorge Emilio Lira-Vera, Ángel Daniel Santana-Vargas, Gabriela Gutiérrez-Reyes, Oscar Morales-Gutiérrez, María de Fátima Higuera-de la Tijera, Diana Montemira-Orozco, Christian Hinojosa-Segura, Moisés Martínez-Castillo, ... José Luis Pérez-Hernández
Ann Hepatol. 2026;31:102149
Full text access
Original article
Different measures of sodium intake and the risk of metabolic dysfunction-associated steatotic liver disease: Evidence from the UK Biobank
Shiqi Zhu, Lihe Liu, Yiping Shen, Rui Li, Jiaxi Lin, Lu Liu, Xiaolin Liu, Hongpeng Sun, Jinzhou Zhu
Ann Hepatol. 2026;31:102145
Full text access
Original article
Simultaneous physical and nutritional intervention reduces frailty in patients with cirrhosis listed for liver transplantation: a randomized controlled trial
Carlos Benítez, Diego Reyes, Catalina Grandy, Isidora Thomas, Nicolás Lavados, Nicole Kim, Anny Gálvez, Silvana Valdés, ... Roberto Candia
Ann Hepatol. 2026;31:102114
Full text access
Original article
Natural history and outcomes of MASLD and MetALD following non-alcoholic fatty liver disease reclassification in a Canadian cohort
Yousef Almahanna, Francisco Idalsoaga, Luis Antonio Díaz, Ahmed Almohsen, Yi Nong Song, Amani Bajunayd, Rokhsana Mortuza, Jeemin Kim, ... Juan Pablo Arab
Ann Hepatol. 2026;31:102166
Full text access
Original article
Reevaluating the clinical course of AMA-positive patients with normal liver enzymes: A large retrospective cohort study
Ahmad Yahia, Fadi Abu Baker, Mifleh Tatour, Rawi Hazzan
Ann Hepatol. 2026;31:102147
Full text access
Original article
Alpha-1 antitrypsin Pi*MZ variant increases the risk of liver disease progression in MASLD and MASH
Bradley Jermy, Jack Brownrigg, Pavel Strnad, Rohit Loomba
Ann Hepatol. 2026;31:102143
Full text access